MedTrace Logo

Treatment of Adipose Tissue and Skin Laxity at the Buttocks by PDLLA, US and RF

NCT07010796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2025-06-11

No results posted yet for this study

Summary

Local body fat and lax skin is treated with a combined approach of PDLLA injections and topical ultrasound and radiofrequency.

Conditions

  • Local Fat Deposits

Interventions

DEVICE

Alma Prime X

Alma Prime x is a platform that provides applicators for radiofrequency and ultrasound.

Sponsors & Collaborators

  • Pablo Naranjo García, MD

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2025-05-15
Completion
2025-05-15
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07010796 on ClinicalTrials.gov